Medical News |
- Comorbidity could alter joint arthroplasty prognosis
- High-dose rifampicin combination could improve meningitis survival
- Optic nerve assessment predicts retinoblastoma outcomes
- Comorbidity could alter joint arthroplasty prognosis
- Parental drinking habits influence those of their children
- High-dose rifampicin combination could improve meningitis survival
| Comorbidity could alter joint arthroplasty prognosis Posted: 20 Dec 2012 04:00 PM PST The long-term outcome of hip and knee arthroplasty may be significantly influenced by comorbidity, suggest results from a large register-based study of over 96,000 osteoarthritis patients. |
| High-dose rifampicin combination could improve meningitis survival Posted: 20 Dec 2012 04:00 PM PST A treatment regimen including high-dose rifampicin administered intravenously in addition to standard or high-dose moxifloxacin has an acceptable safety profile and could improve survival for patients with tuberculous meningitis, indicate phase II trial results. |
| Optic nerve assessment predicts retinoblastoma outcomes Posted: 20 Dec 2012 04:00 PM PST Magnetic resonance imaging scans taken pre- and post-neoadjuvant chemotherapy for International Retinoblastoma Staging System stage III retinoblastoma can indicate a patient's likely event-free and overall survival, indicate study results. |
| Comorbidity could alter joint arthroplasty prognosis Posted: 20 Dec 2012 04:00 PM PST The long-term outcome of hip and knee arthroplasty may be significantly influenced by comorbidity, suggest results from a large register-based study of over 96,000 osteoarthritis patients. |
| Parental drinking habits influence those of their children Posted: 20 Dec 2012 04:00 PM PST Adolescents who have memories of their parents drinking alcohol are at an increased risk for starting to drink alcohol earlier than those who do not, research shows. |
| High-dose rifampicin combination could improve meningitis survival Posted: 20 Dec 2012 04:00 PM PST A treatment regimen including high-dose rifampicin administered intravenously in addition to standard or high-dose moxifloxacin has an acceptable safety profile and could improve survival for patients with tuberculous meningitis, indicate phase II trial results. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment